CD34 expression by embryonic hematopoietic and endothelial cells does not require c-Myb

Area of Science:

• Hematopoiesis
• Developmental Biology
• Molecular Biology

Background:

• CD34 is a crucial cell-surface glycoprotein marker for hematopoietic stem and progenitor cells.
• The role of transcription factors like c-Myb in regulating CD34 expression during development is not fully understood.

Purpose of the Study:

• To investigate the role of c-Myb in the regulation of CD34 expression during developmental hematopoiesis.
• To determine if c-Myb is necessary for CD34 expression in early embryonic hematopoietic development.

Main Methods:

• Analysis of CD34 expression in c-Myb-null embryonic stem cells and embryos.
• In vitro differentiation of embryonic stem cells into embryoid bodies.
• Transient transfections to assess CD34 promoter activity.
• Immunohistochemical analysis of CD34 protein expression in embryonic tissues.

Main Results:

• c-Myb can induce CD34 expression in various cell types and enhances CD34 promoter activity in myeloid cells.
• c-Myb is not required for CD34 expression in primitive hematopoietic cells or endothelial cells in early embryonic development (E8.5).
• In later embryonic development (E12.5), c-Myb deficiency leads to a shift from hematopoietic to endothelial CD34+ cells, indicating a role in definitive hematopoiesis.

Conclusions:

• c-Myb is not essential for the initial CD34 expression in primitive hematopoietic and endothelial cells.
• c-Myb plays a critical role in enabling definitive hematopoiesis and subsequent CD34 expression in the developing embryo.
• These findings highlight a stage-specific requirement for c-Myb in hematopoietic development.